[
    {
        "other_ids": [],
        "amendment_date": null,
        "keywords": [
            "Prostate cancer",
            "Metastatic castration resistant",
            "Aggressive variant",
            "Anaplastic",
            "Neuroendocrine",
            "Homologous recombination deficiency",
            "MSI-H",
            "CDK12"
        ],
        "dcp_id": null,
        "interventional_model": "Parallel",
        "lead_org": "Xencor, Inc.",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Inclusion Criteria:\r\n\r\n          -  Able to provide written informed consent\r\n\r\n          -  Adult (age \u2265 18 years)\r\n\r\n          -  Histologically confirmed diagnosis of carcinoma of the prostate\r\n\r\n          -  Documented progressive mCRPC based on at least one of the following criteria:\r\n\r\n               -  PSA progression, defined as at least 2 rises in PSA with a minimum of a 1 week\r\n                  interval (1.0 ng/mL is the minimal starting value if confirmed rise is the only\r\n                  indication of progression)\r\n\r\n               -  Soft-tissue progression per RECIST 1.1\r\n\r\n               -  Progression of bone disease (evaluable disease) or 2 or more new bone lesions by\r\n                  bone scan\r\n\r\n          -  Progression after treatment with at least 2 prior lines of anticancer therapy approved\r\n             for treatment of metastatic prostate cancer; prior treatment of subjects in Cohort D\r\n             (MSI-H or MMRD) must include a checkpoint inhibitor approved by FDA for that\r\n             indication\r\n\r\n          -  Subjects who did not have a surgical orchiectomy must be on androgen suppression\r\n             treatment (eg, luteinizing hormone-releasing hormone agonist) with castrate level of\r\n             testosterone (\u2264 50 ng/dL) and be willing to continue the treatment throughout the\r\n             study\r\n\r\n          -  Prior targeted or whole exome sequencing panel performed by CLIA-certified laboratory\r\n             documenting:\r\n\r\n               1. Cohort A (AVPCa) - Aggressive variant prostate cancer\r\n\r\n               2. Cohort B or C (HRD) - Homologous recombination deficient (HRD) tumor\r\n\r\n               3. Cohort D (MSI-H/MMRD) - Microsatellite instability-high (MSI-H) or mismatch\r\n                  repair deficient (MMRD) tumors (MSI-H/MMRD)\r\n\r\n               4. Cohort E (No Targetable Mutations) - Not eligible for Cohorts A, B, C, or D\r\n\r\n          -  Evaluable disease according to PCWG3 criteria\r\n\r\n          -  Adequate archival metastatic tumor tissue or agree to undergo a biopsy of at least 1\r\n             metastatic site (fresh biopsy of primary prostate is only allowed if there is clear\r\n             local disease and no other measurable disease site or biopsiable bone lesion)\r\n\r\n          -  ECOG performance status of 0 or 1\r\n\r\n          -  Able and willing to complete the study according to the study schedule\r\n\r\n        Exclusion Criteria:\r\n\r\n        Currently receiving anticancer therapies other than androgen deprivation therapy\r\n\r\n          -  Treatment with any other anticancer therapy within 2 weeks of the start of study drug\r\n             (ie, other immunotherapy, chemotherapy, radiation therapy, etc.)\r\n\r\n          -  Prior treatment with any cytotoxic T-lymphocyte-associated protein (CTLA4), PD1, PDL1,\r\n             or programmed cell death ligand 2 (PDL2) directed immunotherapy, except subjects in\r\n             Cohort D, who will have had prior FDA-approved checkpoint inhibitor therapy\r\n\r\n          -  Grade 4 immune-mediated adverse events related to prior immunotherapy (applicable to\r\n             subjects eligible for Cohort D)\r\n\r\n          -  Failure to recover from any toxicity related to previous anticancer treatment to \u2264\r\n             Grade 2\r\n\r\n          -  Have known active central nervous system metastases and/or carcinomatous meningitis.\r\n             Subjects with previously treated brain metastases may participate provided they are\r\n             radiologically stable, ie, are without evidence of progression for at least 4 weeks by\r\n             repeat imaging (note that the repeat imaging should be performed during study\r\n             screening), are clinically stable, and are without requirement of steroid treatment\r\n             for at least 14 days prior to first dose of study treatment.\r\n\r\n          -  Platelet count < 100 \u00d7 109/L\r\n\r\n          -  Hemoglobin level \u2264 9.0 g/dL\r\n\r\n          -  Absolute neutrophil count \u2264 1.7 \u00d7 109 for subjects who will receive cabazitaxel; < 1.0\r\n             \u00d7 109/L for all others\r\n\r\n          -  Aspartate aminotransferase at screening > 3 \u00d7 upper limit of normal (ULN) for subjects\r\n             without known liver involvement by tumor or > 5 \u00d7 ULN for subjects with known liver\r\n             involvement by tumor\r\n\r\n          -  Alanine aminotransferase at screening > 3 \u00d7 ULN for subjects without known liver\r\n             involvement by tumor or > 5 \u00d7 ULN for subjects with known liver involvement by tumor\r\n\r\n          -  Bilirubin \u2265 1.5 \u00d7 ULN (unless prior diagnosis and documentation of ongoing hemolysis\r\n             or Gilbert's syndrome has been made)\r\n\r\n          -  Estimated creatinine clearance < 50 mL/minute calculated by the Cockcroft Gault or\r\n             Modification of Diet in Renal Disease formulas\r\n\r\n          -  Active known or suspected autoimmune disease (except vitiligo; type 1 diabetes\r\n             mellitus or residual hypothyroidism due to an autoimmune condition that is treatable\r\n             with hormone replacement therapy only; psoriasis, atopic dermatitis, or another\r\n             autoimmune skin condition that is managed without systemic therapy; or arthritis that\r\n             is managed without systemic therapy beyond oral acetaminophen and nonsteroidal\r\n             anti-inflammatory drugs)\r\n\r\n          -  Have any condition requiring systemic treatment with corticosteroids, prednisone\r\n             equivalents, or other immunosuppressive medications within 14 days prior to first dose\r\n             of study drug (except inhaled or topical corticosteroids or brief courses of\r\n             corticosteroids given for prophylaxis of contrast dye allergic response). Subjects who\r\n             are currently taking prednisone from a previous prostate cancer therapy will be\r\n             permitted to enroll in the study.\r\n\r\n          -  Receipt of an organ allograft\r\n\r\n          -  Known history of left ventricular ejection fraction \u2264 40%\r\n\r\n          -  History or evidence of any other clinically unstable/uncontrolled disorder, condition,\r\n             or disease other than their primary malignancy that, in the opinion of the\r\n             Investigator, would pose a risk to patient safety or interfere with study evaluations,\r\n             procedures, or completion\r\n\r\n          -  Evidence of any serious bacterial, viral, parasitic, or systemic fungal infections\r\n             within the 30 days prior to the first dose of study drug\r\n\r\n          -  Receipt of a live-virus vaccine within 30 days prior to the first dose of study drug\r\n             (seasonal flu vaccines that do not contain live virus are permitted)\r\n\r\n          -  A human immunodeficiency virus (HIV) positive subject with CD4+ T-cell (CD4+) counts <\r\n             350 cells/\u03bcL, or an HIV viral load greater than 400 copies/mL, or a history of an AIDS\r\n             (acquired immunodeficiency syndrome)-defining opportunistic infection within the past\r\n             12 months, or who has not been on established antiretroviral therapy (ART) for at\r\n             least 4 weeks prior to initiation of study drug dosing. (Effective ART is defined as a\r\n             drug, dosage, and schedule associated with reduction and control of the viral load.)\r\n\r\n          -  Positive test for hepatitis C RNA (a subject who is hepatitis C virus [HCV] antibody\r\n             positive but HCV RNA negative due to documented, curative prior antiviral treatment or\r\n             natural resolution is eligible)\r\n\r\n          -  Positive test for hepatitis B surface antigen (HBsAg) or hepatitis B core antibody\r\n             (HBcAb; a subject whose HBsAg is negative and HBcAb is positive may be enrolled if a\r\n             hepatitis B virus [HBV] DNA test is negative and the subject is retested for HBsAg and\r\n             HBV DNA every 2 months)"
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "MALE",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "Detailed Description:\r\n\r\n      This is a Phase 2, open-label, multiple-dose, multiple-arm, parallel assignment study in\r\n      patients with mCRPC who have progressed after treatment with at least 2 prior lines of\r\n      anticancer therapy. It will enroll subjects into one of 5 molecularly defined cohorts based\r\n      on the results of acceptable, documented prior diagnostic testing:\r\n\r\n        -  Cohort A: Aggressive variant (anaplastic) adenocarcinoma of the prostate (AVPCa)\r\n\r\n        -  Cohort B: Homologous recombination deficient (HRD)/cyclin-dependent kinase 12 (CDK12)\r\n           mutation positive tumors that have progressed on poly-adenosine diphosphate ribose\r\n           polymerase inhibitors (HRD/CDK12 PARP Progressors)\r\n\r\n        -  Cohort C: HRD/CDK12 mutation positive tumors not previously treated with PARP inhibitors\r\n           (HRD/CDK12 PARP Na\u00efve)\r\n\r\n        -  Cohort D: Microsatellite instability-high (MSI-H) or mismatch repair deficient (MMRD)\r\n           tumors (MSI-H/MMRD)\r\n\r\n        -  Cohort E: No Targetable Mutations\r\n\r\n      Subjects will receive XmAb20717 alone (Cohort D) or in combination with standard therapy\r\n      (XmAb20717 + carboplatin + cabazitaxel [or docetaxel if no prior treatment]: Cohorts A, B,\r\n      and E; XmAb20717 + olaparib: Cohort C).",
        "official_title": "Phase 2 Multiple-Dose, Multiple-Arm, Parallel Assignment Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of XmAb\u00ae20717 Alone or in Combination With Chemotherapy or Targeted Therapies in Selected Subjects With Metastatic Castration-Resistant Prostate Cancer",
        "_phase_sort_order": 2,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "8 weeks",
                "name": "Bone scans based on PCWG3 criteria",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "8 weeks",
                "name": "Duration of response (RECIST 1.1, as modified by PCWG3)",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "8 weeks",
                "name": "Incidence of treatment-emergent adverse events (safety and tolerability of XmAb20717)",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "8 weeks",
                "name": "Objective response rate (RECIST 1.1, as modified by PCWG3)",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "8 weeks",
                "name": "Prostate-specific antigen (PSA) response",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "8 weeks",
                "name": "Radiographic progression-free survival (PCWG3)",
                "description": null,
                "type_code": "SECONDARY"
            }
        ],
        "phase": "II",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 5,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT05005728",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C138961",
                "name": "PSA Level Finding",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C77140",
                    "C3367",
                    "C36292",
                    "C26585",
                    "C25804",
                    "C26003",
                    "C21281"
                ],
                "parents": [
                    "C26585",
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C157377",
                "name": "Testosterone Level Finding",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C36292",
                    "C77140",
                    "C3367"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C129259",
                "name": "Castration Levels of Testosterone",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C157377",
                    "C36292",
                    "C77140",
                    "C3367"
                ],
                "parents": [
                    "C157377"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Protease Gene",
                    "Proteinase Gene"
                ],
                "nci_thesaurus_concept_id": "C26003",
                "name": "Peptidase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21281",
                    "C25804"
                ],
                "parents": [
                    "C25804"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Hydrolase Family Gene"
                ],
                "nci_thesaurus_concept_id": "C25804",
                "name": "Hydrolase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "KLK3",
                    "Kallikrein 3, (Prostate Specific Antigen) Gene",
                    "PSA"
                ],
                "nci_thesaurus_concept_id": "C26585",
                "name": "KLK3 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C26003",
                    "C21281",
                    "C25804",
                    "C16612"
                ],
                "parents": [
                    "C26003"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "Elevated PSA",
                    "Elevated Prostate Specific Antigen",
                    "Increasing PSA",
                    "PSA Elevated",
                    "Prostate Specific Antigen Progression",
                    "Rising PSA"
                ],
                "nci_thesaurus_concept_id": "C123611",
                "name": "PSA Progression",
                "semantic_types": [
                    "Finding",
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C26585",
                    "C25804",
                    "C16612",
                    "C3367",
                    "C26003",
                    "C138961",
                    "C77140",
                    "C36292",
                    "C21281"
                ],
                "parents": [
                    "C138961",
                    "C26585"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2021-10-22",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Castration-Resistant Prostate Carcinoma",
                    "Castration-Resistant Prostate Carcinoma",
                    "CRPC"
                ],
                "nci_thesaurus_concept_id": "C130234",
                "name": "Castration-Resistant Prostate Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8946",
                    "C167255"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Prostate Carcinoma AJCC v8",
                    "Stage IV Prostate Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140173",
                "name": "Stage IV Prostate Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140163"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVA Prostate Cancer AJCC v8",
                    "Stage IVA Prostate Carcinoma AJCC v8",
                    "IVA"
                ],
                "nci_thesaurus_concept_id": "C140174",
                "name": "Stage IVA Prostate Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140173"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "IVB",
                    "Stage IVB Prostate Carcinoma AJCC v8",
                    "Stage IVB Prostate Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140175",
                "name": "Stage IVB Prostate Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140173"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prostate Carcinoma Metastatic",
                    "Prostate Cancer Metastatic",
                    "Metastatic Prostate Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C8946",
                "name": "Metastatic Prostate Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4863",
                    "C146893"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Reproductive System Tumor",
                    "Neoplasm of Reproductive System",
                    "Reproductive Tumor",
                    "Tumor of the Reproductive System",
                    "Tumor of Reproductive System",
                    "Neoplasm of the Reproductive System",
                    "Reproductive Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C3674",
                "name": "Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156482",
                    "C4875"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36310",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor Morphology",
                    "Tumor_Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm of the Prostate",
                    "Neoplasm of Prostate",
                    "Prostate Tumor",
                    "Tumor of the Prostate",
                    "Tumor of Prostate"
                ],
                "nci_thesaurus_concept_id": "C3343",
                "name": "Prostate Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3054",
                    "C26865"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Tumor of the Male Reproductive System",
                    "Malignant Male Reproductive System Tumor",
                    "Male reprod. system cancer, NOS",
                    "Malignant Neoplasm of the Male Reproductive System",
                    "Malignant Tumor of Male Reproductive System",
                    "Malignant Neoplasm of Male Reproductive System",
                    "Male reproductive system cancer, NOS"
                ],
                "nci_thesaurus_concept_id": "C8561",
                "name": "Malignant Male Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3054",
                    "C36076"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C167255",
                "name": "Refractory Prostate Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4863",
                    "C177149"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36076",
                "name": "Malignant Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C3674"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Genitourinary Cancer",
                    "Metastatic Genitourinary Carcinoma",
                    "Metastatic Urogenital Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C146893",
                "name": "Metastatic Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C164141",
                    "C157774"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Prostate Disease"
                ],
                "nci_thesaurus_concept_id": "C26865",
                "name": "Prostate Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27019"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Genitourinary Disorder",
                    "Urogenital Disease"
                ],
                "nci_thesaurus_concept_id": "C156660",
                "name": "Genitourinary System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, secondary",
                    "Secondary Tumor",
                    "Tumor, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "resistant cancer",
                    "Refractory Cancer",
                    "clinical resistance"
                ],
                "nci_thesaurus_concept_id": "C120186",
                "name": "Refractory Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C7628"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma of Prostate",
                    "Prostate cancer, NOS",
                    "Cancer of Prostate",
                    "Prostate Carcinoma",
                    "Carcinoma of the Prostate",
                    "Cancer of the Prostate"
                ],
                "nci_thesaurus_concept_id": "C4863",
                "name": "Prostate Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C181196",
                    "C7378"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Neoplasm of Prostate",
                    "Malignant Tumor of the Prostate",
                    "Malignant Neoplasm of the Prostate",
                    "Malignant Prostate Tumor",
                    "Malignant Tumor of Prostate"
                ],
                "nci_thesaurus_concept_id": "C7378",
                "name": "Malignant Prostate Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8561",
                    "C3343"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Malignant Genitourinary System Neoplasm",
                    "Metastatic Genitourinary System Malignant Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C157774",
                "name": "Metastatic Genitourinary Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C156484"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Malignancy",
                    "Secondary Cancer"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C36255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156482",
                "name": "Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C150534",
                "name": "Refractory Malignant Male Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8561",
                    "C120186"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C164141",
                "name": "Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Malignant Epithelial Neoplasm",
                    "Epithelial Carcinoma",
                    "Malignant Epithelioma",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Epithelial tumor, malignant",
                    "Epithelioma Malignant"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3709",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C8511",
                "name": "Refractory Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C120186"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Refractory Tumor"
                ],
                "nci_thesaurus_concept_id": "C7628",
                "name": "Refractory Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C181196",
                "name": "Male Reproductive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8561",
                    "C164141"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disorder of Male Reproductive System",
                    "Male Reproductive System Disease"
                ],
                "nci_thesaurus_concept_id": "C27019",
                "name": "Male Reproductive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4875"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Tumor",
                    "Tumor, metastatic",
                    "Neoplasm, metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Genitourinary Neoplasm",
                    "Genitourinary System Cancer",
                    "Genitourinary Cancer"
                ],
                "nci_thesaurus_concept_id": "C156484",
                "name": "Malignant Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C156482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C177149",
                "name": "Refractory Male Reproductive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C181196",
                    "C150534",
                    "C8511"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Genital Disorders",
                    "Reproductive System Disease",
                    "Disorder of Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C4875",
                "name": "Reproductive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor of Male Reproductive System",
                    "Tumor of the Male Reproductive System",
                    "Neoplasm of Male Reproductive System",
                    "Neoplasm of the Male Reproductive System",
                    "Male Reproductive System Tumor"
                ],
                "nci_thesaurus_concept_id": "C3054",
                "name": "Male Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3674",
                    "C27019"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Prostate Carcinoma by AJCC v8 Stage",
                    "Tumor Stage (Pathologic)"
                ],
                "nci_thesaurus_concept_id": "C140163",
                "name": "Prostate Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4863"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "XmAb20717-04",
        "active_sites_count": 4,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Tubulin Binding Agents"
                        ],
                        "nci_thesaurus_concept_id": "C25974",
                        "name": "Tubulin Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C273"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2842",
                        "name": "DNA Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C141144",
                        "name": "Immune Checkpoint Modulator",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Chemotherapy Alkylating Agents",
                            "Chemotherapy Alkylators"
                        ],
                        "nci_thesaurus_concept_id": "C1590",
                        "name": "Antineoplastic Alkylating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2842"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Lynparza"
                        ],
                        "nci_thesaurus_concept_id": "C71721",
                        "name": "Olaparib",
                        "description": "A small molecule inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential chemosensitizing, radiosensitizing, and antineoplastic activities. Olaparib selectively binds to and inhibits PARP, inhibiting PARP-mediated repair of single strand DNA breaks; PARP inhibition may enhance the cytotoxicity of DNA-damaging agents and may reverse tumor cell chemoresistance and radioresistance. PARP catalyzes post-translational ADP-ribosylation of nuclear proteins and can be activated by single-stranded DNA breaks. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C62554"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antiproliferative Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antiproliferative Drugs",
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Cancer Drug",
                            "Antineoplastics",
                            "Anti-Tumor Drugs",
                            "Antineoplastic Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Antibody",
                            "Antineoplastic Ab",
                            "Anticancer Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Taxanes"
                        ],
                        "nci_thesaurus_concept_id": "C1490",
                        "name": "Taxane Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C860"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Agent",
                            "Enzyme Inhibitor Drug"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C28227",
                        "name": "Bispecific Monoclonal Antibody",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1454",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2163",
                        "name": "DNA Adduct Forming Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2842"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hydrocarbons"
                        ],
                        "nci_thesaurus_concept_id": "C552",
                        "name": "Hydrocarbon",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C718"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibodies",
                            "Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C307",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent",
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1913",
                        "name": "Drug or Chemical by Structure",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-CTLA4 Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C128036",
                        "name": "Anti-CTLA-4 Monoclonal Antibody",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C20401",
                            "C141144",
                            "C163758"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunopotentiators",
                            "Biological Response Modifier",
                            "BRM",
                            "Immune Regulators",
                            "Immune Modulators",
                            "Immune Mediators",
                            "Biomodulators",
                            "Immunomodulating Agent",
                            "Immunomodulators",
                            "Immunotherapeutic Agent",
                            "Immunomodulatory Agent",
                            "Immunotherapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C718",
                        "name": "Organic Chemical",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1913"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Lipids"
                        ],
                        "nci_thesaurus_concept_id": "C616",
                        "name": "Lipid",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C718"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Terpenes"
                        ],
                        "nci_thesaurus_concept_id": "C860",
                        "name": "Terpene Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C552",
                            "C616"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Radiation Sensitizers",
                            "Radiosensitizers",
                            "Radiosensitizing Drugs",
                            "Radiation-Sensitizing Agents",
                            "Radiation-Sensitizing Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C798",
                        "name": "Radiosensitizing Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmaceuticals",
                            "Agent",
                            "Pharmacological Substance",
                            "Drug Substance",
                            "Pharmaceutical Agent",
                            "Drug",
                            "Pharmacologic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Platinum-Based Chemotherapy",
                            "Platinum Agents"
                        ],
                        "nci_thesaurus_concept_id": "C1450",
                        "name": "Platinum Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2163",
                            "C1590",
                            "C798"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C150463",
                        "name": "Vudalimab",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C28227",
                            "C129822",
                            "C128036"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Poly (ADP-Ribose) Polymerase Inhibitor",
                            "Poly(ADP-Ribose) Polymerase Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C62554",
                        "name": "PARP Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C471",
                            "C163758"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Bispecific Antibodies"
                        ],
                        "nci_thesaurus_concept_id": "C1454",
                        "name": "Bispecific Antibody",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C307",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Platinwas",
                            "Carbosol",
                            "Carbotec",
                            "Paraplatine",
                            "Paraplatin AQ",
                            "Carbosin",
                            "Displata",
                            "Ercar",
                            "Nealorin",
                            "Blastocarb",
                            "Novoplatinum",
                            "Carboplat",
                            "Ribocarbo"
                        ],
                        "nci_thesaurus_concept_id": "C1282",
                        "name": "Carboplatin",
                        "description": "A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C1450"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Taxane-Site Binding Agent"
                        ],
                        "nci_thesaurus_concept_id": "C67437",
                        "name": "Taxane-Pocket Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C25974"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Jevtana"
                        ],
                        "nci_thesaurus_concept_id": "C66937",
                        "name": "Cabazitaxel",
                        "description": "A semi-synthetic derivative of the natural taxoid 10-deacetylbaccatin III with potential antineoplastic activity. Cabazitaxel binds to and stabilizes tubulin, resulting in the inhibition of microtubule depolymerization and cell division, cell cycle arrest in the G2/M phase, and the inhibition of tumor cell proliferation. Unlike other taxane compounds, this agent is a poor substrate for the membrane-associated, multidrug resistance (MDR), P-glycoprotein (P-gp) efflux pump and may be useful for treating multidrug-resistant tumors. In addition, cabazitaxel penetrates the blood-brain barrier (BBB). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C67437",
                            "C1490"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunologic, Immunochemical",
                            "Immunologics",
                            "Biopharmaceuticals",
                            "Biologicals",
                            "Biologics",
                            "Biological Products"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biological",
                            "Anticancer Biological",
                            "Anti-cancer Biological Agent",
                            "Antineoplastic Biotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Mitosis Inhibitor Drugs",
                            "Antimitotic Drugs",
                            "Mitosis Inhibitors",
                            "Mitotic Inhibitor Drugs",
                            "Antimitotics",
                            "Mitotic Inhibitors",
                            "Microtubular Function Inhibitors",
                            "Mitosis Inhibitor Agents",
                            "Mitotic Inhibitor Agents"
                        ],
                        "nci_thesaurus_concept_id": "C273",
                        "name": "Antimitotic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "Cohort A - AVPCa",
                "description": "XmAb20717 + carboplatin + cabazitaxel",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Cohort B - HRD/CDK12 PARP - Progressors",
                "description": "XmAb20717 + carboplatin + cabazitaxel",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Cohort C - HRD/CDK12 PARP Na\u00efve",
                "description": "XmAb20717 + olaparib",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Cohort D - MSI-H or MMRD",
                "description": "XmAb20717 monotherapy",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Cohort E - No Targetable Mutations",
                "description": "XmAb20717 + carboplatin + cabazitaxel",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2021-09181",
        "why_study_stopped": null,
        "brief_summary": "This Phase 2 study will investigate the safety and clinical activity of XmAb20717 alone or in\r\n      combination with standard of care anticancer therapies in patients with metastatic\r\n      castration-resistant prostate cancer (mCRPC) who have been treated with at least 2 prior\r\n      lines of anticancer therapy.",
        "brief_title": "XmAb\u00ae20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer",
        "status_history": [
            {
                "status_date": "2021-10-22T00:00:00.000001",
                "status": "ACTIVE"
            },
            {
                "status_date": "2021-08-12T00:00:00",
                "status": "IN_REVIEW"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 85,
        "_current_trial_status_sort_order": 0,
        "start_date": "2021-10-22",
        "record_verification_date": "2022-01-01",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Non-Randomized Trial"
        },
        "acronym": null,
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Prostate"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2024-06-30",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]